EW Projected Dividend Yield
Edwards Lifesciences Corp ( NYSE : EW )Edwards Lifesciences Corporation is a global structural heart innovation company. Co. is engaged in patient-focused medical innovations for structural heart disease and invests in research and development to transform care for those impacted by structural heart disease. Its products are categorized into groups, including Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), and Surgical Structural Heart (Surgical). It develops transcatheter heart valve replacement technologies designed for the minimally invasive replacement of aortic heart valves. 21 YEAR PERFORMANCE RESULTS |
EW Dividend History Detail EW Dividend News EW Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |